Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases

BACKGROUND AND IMPORTANCE: Recurrent malignant gliomas (RMGs) are very difficult to control, and no standard treatments have been established for them. We performed boron neutron capture therapy (BNCT) for patients with RMG. BNCT enables high-dose particle radiation to be applied selectively to tumo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Miyatake, Shin-Ichi, Kawabata, Shinji, Hiramatsu, Ryo, Furuse, Motomasa, Kuroiwa, Toshihiko, Suzuki, Minoru
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2014
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3923505/
https://ncbi.nlm.nih.gov/pubmed/24387301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1748-717X-9-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi